The company will have to announce partnership with some big pharma companies in order for this stock to move up. No matter what they announce, CE mark, accelerates European Market Development, advances Pivotal US study, the stock still went down. The only explanation for the downward movement is stock manipulation. Just hold on to your shares folks.
Agree, there is so much of this, market makers, warrant holders, the stock is under accumulation while it goes down. Then all of a sudden, a stock will shoot up 22% like what happened today with ADXS, which I have watched but don't own. My most undervalued stock is ATRS. I have a large position in APPY and ATRS. When it turns it will turn fast without warning. Hold your shares, this one is going to outperform eventually.
I think people are in denial as to why, after all of the absolutely massive selling by institutions, no other institutions came in to buy. This stock is a tease and a poor example of a listed stock. I can't think of any stock that had to reverse splits in about one year (1 for 5 and 1 for 6). That just reeks of a poor stock/company. GL to you.
Taking the stock and the APPY1 test for what it is and where it is today, this is relevant, more relevant than their R/S's and how management has performed in the past. I am looking for EU revenues and commercialization success to precede an FDA approval in the US. Once approved here this stock is going to $20, that's why I'm here. I can wait, that's where the money is made.